Spheroplast
A spheroplast (or sphaeroplast in British usage) is a microbial cell from which the cell wall has been almost completely removed, as by the action of penicillin. According to some definitions, the term is used to describe Gram-negative bacteria.[3] According to other definitions, the term also encompasses yeast cells.[4] The name spheroplast stems from the fact that after the microbe's cell wall is digested, membrane tension causes the cell to acquire a characteristic spherical shape. Spheroplasts are osmotically fragile, and will lyse if transferred to a hypotonic solution.[4]
When used to describe Gram-negative bacteria, the term spheroplast refers to cells from which the peptidoglycan component but not the outer membrane component of the cell wall has been removed.[4]
Spheroplast formation
Antibiotic-induced spheroplasts
Various antibiotics convert Gram-negative bacteria into spheroplasts. These include peptidoglycan synthesis inhibitors such as fosfomycin, vancomycin, moenomycin, lactivicin and the β-lactam antibiotics.[1][2] Antibiotics that inhibit biochemical pathways directly upstream of peptidoglycan synthesis induce spheroplasts too (eg. fosmidomycin, phosphoenolpyruvate).[1][2]
In addition to the above antibiotics, inhibitors of protein synthesis (eg. chloramphenicol, oxytetracycline, several aminoglycosides) and inhibitors of folic acid synthesis (eg. trimethoprim, sulfamethoxazole) also cause Gram-negative bacteria to form spheroplasts.[2]
Enzyme-induced spheroplasts
The enzyme lysozyme causes Gram-negative bacteria to form spheroplasts, but only if a membrane permeabilizer such as lactoferrin or ethylenediaminetetraacetate (EDTA) is used to ease the enzyme’s passage through the outer membrane.[2][5] EDTA acts as a permeabilizer by binding to divalent ions such as Ca2+ and removing them from the outer membrane.[6]
Uses and applications
Antibiotic discovery
From the 1960s into the 1990s, Merck and Co. used a spheroplast screen as a primary method for discovery of antibiotics that inhibit cell wall biosynthesis. In this screen devised by Eugene Dulaney, growing bacteria were exposed to test substances under hypertonic conditions. Inhibitors of cell wall synthesis caused growing bacteria to form spheroplasts. This screen enabled the discovery of fosfomycin, cephamycin C, thienamycin and several carbapenems.[1]
Patch clamping
Specially prepared giant spheroplasts of Gram-negative bacteria can be used to study the function of bacterial ion channels through a technique called patch clamp, which was originally designed for characterizing the behavior of neurons and other excitable cells. To prepare giant spheroplasts, bacteria are treated with a septation inhibitor (eg. cephalexin). This causes the bacteria to form filaments, elongated cells that lack internal cross-walls.[7] After a period of time, the cell walls of the filaments are digested, and the bacteria collapse into very large spheres surrounded by just their cytoplasmic and outer membranes. The membranes can then be analyzed on a patch clamp apparatus to determine the phenotype of the ion channels embedded in it. It is also common to overexpress a particular channel to amplify its effect and make it easier to characterize.
The technique of patch clamping giant E. coli spheroplasts has been used extensively for studying the native mechanosensitive channels (MscL, MscS, and MscM) of E. coli since 1987.[8][9] It has been extended to study other heterologously expressed ion channels and it has been shown that the giant E. coli spheroplast can be used as an ion-channel expression system comparable to the Xenopus oocyte.[10][11][12][13]
Cell lysis
Yeast cells are normally protected by a thick cell wall which makes extraction of cellular proteins difficult. Enzymatic digestion of the cell wall with zymolyase, creating spheroplasts, renders the cells vulnerable to easy lysis with detergents or rapid osmolar pressure changes.[citation needed]
Transfection
Bacterial spheroplasts, with suitable recombinant DNA inserted into it, can be used to transfect animal cells. Spheroplasts with recombinant DNA are introduced into the media containing animal cells and are fused by polyethylene glycol (PEG). With this methodology, nearly 100% of the animal cells may take up the foreign DNA.[14] Upon conducting experiments following a modified Hanahan protocol using calcium chloride in E. coli, it was determined that spheroplasts may be able to transform at 4.9x10−4.[15]
See also
References
- ^ a b c d Silver, L.L (2011). "Chapter 2, Rational approaches to antibiotic discovery: pre-genomic directed and phenotypic screening". In Dougherty, T.; Pucci, M.J. (eds.). Antibiotic Discovery and Development. Springer. pp. 33–75. ISBN 978-1-4614-1400-1.
{{cite book}}
: Cite has empty unknown parameter:|lastauthoramp=
(help); External link in
(help); Unknown parameter|chapterurl=
|chapterurl=
ignored (|chapter-url=
suggested) (help) - ^ a b c d e Cushnie, T.P.; O’Driscoll, N.H.; Lamb, A.J. (2016). "Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action". Cellular and Molecular Life Sciences. 73 (23): 4471–4492. doi:10.1007/s00018-016-2302-2. PMID 27392605.
- ^ "Spheroplast". Dictionary.com. Dictionary.com. 2019. Retrieved July 18, 2019.
- ^ a b c "Protoplasts and spheroplasts". Encylopedia.com. Encylopedia.com. 2016. Retrieved July 18, 2019.
- ^ Tortora, Gerard; Funke, Berdell; Case, Christine (2016). Microbiology: An Introduction. United States: Pearson. p. 84. ISBN 0-321-92915-2.
- ^ Ninfa, Alexander J.; Ballou, David P.; Benore, Marilee (2010). Fundamental Laboratory Approaches for biochemistry and Biotechnology (2nd ed.). United States of America: John Wiley & Sons, Inc. p. 234. ISBN 978-0-470-08766-4.
- ^ Kikuchi, K.; Sugiura, M.; Nishizawa-Harada, C.; Kimura, T. (2015). "The application of the Escherichia coli giant spheroplast for drug screening with automated planar patch clamp system" (PDF). Biotechnology Reports. 7: 17–23. doi:10.1016/j.btre.2015.04.007. PMID 28626710.
- ^ Martinac, B., Buechner, M., Delcour, A. H., Adler, J., and Kung, C. (1987) Pressure-sensitive ion channel in Escherichia coli. Proc. Natl. Acad. Sci. USA 84, 2297-2301.
- ^ Blount, P., Sukharev, S. I., Moe, P. C., Martinac, B., and Kung, C. (1999) Mechanosensitive channels of bacteria. Methods in Enzymology 294, 458-482.
- ^ Santos, J. S., Lundby, A., Zazueta, C., and Montal, M. (2006) Molecular template for a voltage sensor in a novel K+ channel. I. Identification and functional characterization of KvLm, a voltage-gated K+ channel from Listeria monocytogenes. Journal of General Physiology 128(3), 283-292.
- ^ Nakayama, Y., Fujiu, K., Sokabe, M., and Yoshimura, K. (2007) Molecular and electrophysiological characterization of a mechanosensitive channel expressed in the chloroplasts of Chlamydomonas. Proc. Natl. Acad. Sci. USA 104, 5883-5888.
- ^ Kuo, M. M.-C., Baker, K. A., Wong, L., and Choe, S. (2007) Dynamic oligomeric conversions of the cytoplasmic RCK domains mediate MthK potassium channel activity. Proc. Natl. Acad. Sci. USA 104, 2151-2156.
- ^ Kuo, M. M.-C., Saimi, Y., Kung, C., and Choe, S. (2007). Patch-clamp and phenotypic analyses of a prokaryotic cyclic nucleotide-gated K+ channel using Escherichia Coli as a host. J. Biol. Chem. 282, 24294-24301.
- ^ Gietz, R. D.; Woods, R. A. (2001-04-01). "Genetic transformation of yeast". BioTechniques. 30 (4): 816–820, 822–826, 828 passim. ISSN 0736-6205. PMID 11314265.
- ^ "The Effect of Spheroplast Formation on the Transformation Efficiency in Escherichia coli DH5α". ResearchGate. Retrieved 2017-05-07.
External links
- Spheroplasts at the U.S. National Library of Medicine Medical Subject Headings (MeSH)